Document Detail

Physical activity in primary vs. secondary prevention indication Implantable Cardioverter Defibrillatore recipients 6-12 months after implantation - a cross-sectional study with register follow up.
MedLine Citation:
PMID:  25448249     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To describe (i) physical activity status among ICD patients according to the indication for ICD implant compared to international guidelines and compared to a matched normal population in order to detect potentials for improved physical outcomes, (ii) patients' beliefs regarding and participation in physical exercise by ICD indication, (iii) factors predicting low physical activity, and (iv) physical activity as a predictor of mortality.
DESIGN: National survey with register follow-up. Comparisons were made to a matched healthy reference population and patients were followed in registers for 15 months.
SETTING: Patients are identified from national registers and questionnaires are distributed by postal mail.
PARTICIPANTS: All diagnostic profiles and indications were included as were both single chamber ICD and biventricular ICD (n=499).
INTERVENTIONS: Not applicable.
MAIN OUTCOME MEASURES: Questions regarding physical activity and the IPAQ questionnaire were used to assess physical activity.
RESULTS: The response rate was 71.7%. Mean age 65.5 years with 82% males. 37% participated in a rehabilitation programme. 21 % were sedentary compared to 8 % in the reference population (p < 0.0001). Only 13 % of patients followed physical exercise guidelines. Low physical activity was predicted by primary prevention indication (OR 2.5; 95%CI (1.3;4.7) and higher co-morbidity (OR 2.1; 95%CI (1.0;4.1) p<0.05. Finally, low physical activity was associated with increased mortality (OR 3.9; 95%CI (1.11;13.71) p<0.05, however not statistically significant when adjusted for age, sex, marital status and co-morbidity.
CONCLUSION: Guidelines for exercise and participation in rehabilitation are not meet for this population which leave a great potential for future interventions improving the clinical outcomes which are modifiable by exercise.
Selina Kikkenborg Berg; Lau Caspar Thygesen; Jesper Hastrup Svendsen; Anne Vinggaard Christensen; Ann-Dorthe Zwisler
Related Documents :
8338169 - Responses of the human esophagus to experimental intraluminal distension.
10468669 - Neuromuscular fatigue during repeated exhaustive submaximal static contractions of knee...
16239279 - Alkalosis increases muscle k+ release, but lowers plasma [k+] and delays fatigue during...
6503029 - Effects of low na on the tetanic contractility of frog skeletal muscle.
9644229 - The effect of beta-blockade on plasma potassium concentrations and muscle excitability ...
11355149 - Physiopathology and treatment of fatigue in multiple sclerosis.
1861479 - Effects of simultaneous training for strength and endurance on upper and lower body str...
24224869 - Tendon structural adaptations to load exercise are inhibited by anabolic androgenic ste...
12906039 - Reversible ischemic neurological deficit (rind) due to exercise testing for the diagnos...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-15
Journal Detail:
Title:  Archives of physical medicine and rehabilitation     Volume:  -     ISSN:  1532-821X     ISO Abbreviation:  Arch Phys Med Rehabil     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-12-2     Completed Date:  -     Revised Date:  2014-12-3    
Medline Journal Info:
Nlm Unique ID:  2985158R     Medline TA:  Arch Phys Med Rehabil     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Non-invasive Brain Stimulation: The Potential for Use in the Rehabilitation of Pediatric Acquired Br...
Next Document:  Enhanced Elimination of Dabigatran Through Extracorporeal Methods.